Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.60
-0.45 (-4.97%)
At close: Nov 21, 2025, 4:00 PM EST
8.79
+0.19 (2.21%)
After-hours: Nov 21, 2025, 7:12 PM EST

Zevra Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
84.3923.6127.4610.1628.6513.29
Upgrade
Revenue Growth (YoY)
244.60%-14.02%170.26%-64.53%115.61%3.50%
Upgrade
Cost of Revenue
16.337.422.170.222.061.31
Upgrade
Gross Profit
68.0616.225.299.9426.5911.98
Upgrade
Selling, General & Admin
73.4454.9235.0915.619.238.44
Upgrade
Research & Development
18.4242.0439.0319.239.648.32
Upgrade
Amortization of Goodwill & Intangibles
5.166.240.77---
Upgrade
Operating Expenses
97.02103.274.8934.8418.8616.76
Upgrade
Operating Income
-28.96-87-49.6-24.97.73-4.78
Upgrade
Interest Expense
-8.22-7.35-1.5-0.34-0.38-7.09
Upgrade
Interest & Investment Income
5.162.184.541.510.260.09
Upgrade
Other Non Operating Income (Expenses)
-3.982.06-0.115.16-0.03-0.18
Upgrade
EBT Excluding Unusual Items
-36.01-90.12-46.66-8.577.59-11.97
Upgrade
Merger & Restructuring Charges
------0.83
Upgrade
Gain (Loss) on Sale of Investments
0.04-0.020.61-0.58-0.01-
Upgrade
Other Unusual Items
-----16.1-
Upgrade
Pretax Income
53.64-90.14-46.05-26.81-8.52-12.79
Upgrade
Income Tax Expense
18.3215.37--0.030.03-0.03
Upgrade
Net Income
35.33-105.51-46.05-26.77-8.56-12.76
Upgrade
Preferred Dividends & Other Adjustments
5.31---54.34-
Upgrade
Net Income to Common
30.02-105.51-46.05-26.77-62.9-12.76
Upgrade
Shares Outstanding (Basic)
55463534304
Upgrade
Shares Outstanding (Diluted)
56463534304
Upgrade
Shares Change (YoY)
31.47%30.46%2.79%15.87%647.72%114.79%
Upgrade
EPS (Basic)
0.55-2.28-1.30-0.78-2.11-3.21
Upgrade
EPS (Diluted)
0.54-2.28-1.30-0.78-2.11-3.21
Upgrade
Free Cash Flow
-24.23-69.67-33.83-18.8110.34-1.97
Upgrade
Free Cash Flow Per Share
-0.43-1.51-0.95-0.550.35-0.49
Upgrade
Gross Margin
80.65%68.59%92.09%97.81%92.81%90.18%
Upgrade
Operating Margin
-34.32%-368.47%-180.63%-245.07%26.98%-35.98%
Upgrade
Profit Margin
35.57%-446.85%-167.69%-263.48%-219.54%-96.03%
Upgrade
Free Cash Flow Margin
-28.71%-295.04%-123.20%-185.12%36.08%-14.84%
Upgrade
EBITDA
-23.62-80.61-48.6-23.967.99-4.51
Upgrade
EBITDA Margin
-27.99%--176.97%-235.78%27.87%-33.92%
Upgrade
D&A For EBITDA
5.346.391.010.940.260.27
Upgrade
EBIT
-28.96-87-49.6-24.97.73-4.78
Upgrade
EBIT Margin
-34.32%--180.63%-245.07%26.98%-35.98%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q